Go Pro

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$3.77 -0.01 (-0.26%)
As of 07/24/2026 04:00 PM Eastern

ACB vs. TLRY, WEED, CPH, SUGR, and FIRE

Should you buy Aurora Cannabis stock or one of its competitors? MarketBeat compares Aurora Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aurora Cannabis include Tilray Brands (TLRY), Canopy Growth (WEED), Cipher Pharmaceuticals (CPH), SugarBud Craft Growers (SUGR), and Supreme Cannabis (FIRE). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Aurora Cannabis compare to Tilray Brands?

Tilray Brands (TSE:TLRY) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Aurora Cannabis has a net margin of -12.13% compared to Tilray Brands' net margin of -158.75%. Aurora Cannabis' return on equity of -7.25% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-158.75% -88.06% -1.41%
Aurora Cannabis -12.13%-7.25%-1.87%

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$858.28M0.79-C$183.24M-C$14.63N/A
Aurora CannabisC$320.59M0.73-C$44.16M-C$2.14N/A

Tilray Brands currently has a consensus target price of C$13.30, suggesting a potential upside of 142.26%. Aurora Cannabis has a consensus target price of C$7.17, suggesting a potential upside of 90.10%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

4.2% of Tilray Brands shares are held by institutional investors. Comparatively, 4.2% of Aurora Cannabis shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Tilray Brands had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 2 mentions for Tilray Brands and 1 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.85 beat Tilray Brands' score of -0.02 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Aurora Cannabis
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Tilray Brands has a beta of 3.0845, indicating that its stock price is 208% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.268291, indicating that its stock price is 73% less volatile than the broader market.

Summary

Tilray Brands and Aurora Cannabis tied by winning 8 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Canopy Growth?

Aurora Cannabis (TSE:ACB) and Canopy Growth (TSE:WEED) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Aurora Cannabis has a beta of 0.268291, suggesting that its stock price is 73% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 1.44612, suggesting that its stock price is 45% more volatile than the broader market.

Aurora Cannabis presently has a consensus price target of C$7.17, suggesting a potential upside of 90.10%. Canopy Growth has a consensus price target of C$1.88, suggesting a potential upside of 47.64%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, research analysts plainly believe Aurora Cannabis is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Canopy Growth
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$320.59M0.73-C$44.16M-C$2.14N/A
Canopy GrowthC$284.60M1.88-C$1.05B-C$0.88N/A

In the previous week, Aurora Cannabis had 1 more articles in the media than Canopy Growth. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Canopy Growth. Aurora Cannabis' average media sentiment score of 1.85 beat Canopy Growth's score of 0.82 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Overall Sentiment
Aurora Cannabis Very Positive
Canopy Growth Positive

Aurora Cannabis has a net margin of -12.13% compared to Canopy Growth's net margin of -84.76%. Aurora Cannabis' return on equity of -7.25% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-12.13% -7.25% -1.87%
Canopy Growth -84.76%-35.48%-3.83%

4.2% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 4.3% of Canopy Growth shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Aurora Cannabis beats Canopy Growth on 10 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Cipher Pharmaceuticals?

Aurora Cannabis (TSE:ACB) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

Cipher Pharmaceuticals has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$320.59M0.73-C$44.16M-C$2.14N/A
Cipher PharmaceuticalsC$50.94M8.10C$11.41MC$1.1913.66

Aurora Cannabis currently has a consensus target price of C$7.17, suggesting a potential upside of 90.10%. Cipher Pharmaceuticals has a consensus target price of C$17.00, suggesting a potential upside of 4.62%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, equities research analysts plainly believe Aurora Cannabis is more favorable than Cipher Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cipher Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

4.2% of Aurora Cannabis shares are held by institutional investors. Comparatively, 2.3% of Cipher Pharmaceuticals shares are held by institutional investors. 42.0% of Cipher Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Aurora Cannabis and Aurora Cannabis both had 1 articles in the media. Aurora Cannabis' average media sentiment score of 1.85 beat Cipher Pharmaceuticals' score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Cipher Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aurora Cannabis has a beta of 0.268291, meaning that its share price is 73% less volatile than the broader market. Comparatively, Cipher Pharmaceuticals has a beta of 1.153706, meaning that its share price is 15% more volatile than the broader market.

Cipher Pharmaceuticals has a net margin of 60.82% compared to Aurora Cannabis' net margin of -12.13%. Cipher Pharmaceuticals' return on equity of 25.69% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-12.13% -7.25% -1.87%
Cipher Pharmaceuticals 60.82%25.69%7.90%

Summary

Cipher Pharmaceuticals beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to SugarBud Craft Growers?

Aurora Cannabis (TSE:ACB) and SugarBud Craft Growers (CVE:SUGR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

SugarBud Craft Growers has a net margin of 2.11% compared to Aurora Cannabis' net margin of -12.13%. SugarBud Craft Growers' return on equity of 10.07% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-12.13% -7.25% -1.87%
SugarBud Craft Growers 2.11%10.07%5.13%

Aurora Cannabis has a beta of 0.268291, meaning that its share price is 73% less volatile than the broader market. Comparatively, SugarBud Craft Growers has a beta of 2.768948, meaning that its share price is 177% more volatile than the broader market.

4.2% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 0.4% of SugarBud Craft Growers shares are owned by institutional investors. 30.2% of SugarBud Craft Growers shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SugarBud Craft Growers has higher revenue and earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than SugarBud Craft Growers, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$320.59M0.73-C$44.16M-C$2.14N/A
SugarBud Craft GrowersC$662.89M0.42C$12.12MC$1.408.21

In the previous week, Aurora Cannabis had 1 more articles in the media than SugarBud Craft Growers. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for SugarBud Craft Growers. Aurora Cannabis' average media sentiment score of 1.85 beat SugarBud Craft Growers' score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Overall Sentiment
Aurora Cannabis Very Positive
SugarBud Craft Growers Neutral

Aurora Cannabis currently has a consensus price target of C$7.17, suggesting a potential upside of 90.10%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, analysts plainly believe Aurora Cannabis is more favorable than SugarBud Craft Growers.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
SugarBud Craft Growers
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

SugarBud Craft Growers beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Supreme Cannabis?

Aurora Cannabis (TSE:ACB) and Supreme Cannabis (TSE:FIRE) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

4.2% of Aurora Cannabis shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Supreme Cannabis has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Supreme Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$320.59M0.73-C$44.16M-C$2.14N/A
Supreme CannabisC$53.29M0.00-C$23.65M-C$0.03N/A

Supreme Cannabis has a net margin of 0.00% compared to Aurora Cannabis' net margin of -12.13%. Supreme Cannabis' return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-12.13% -7.25% -1.87%
Supreme Cannabis N/A N/A N/A

In the previous week, Aurora Cannabis had 1 more articles in the media than Supreme Cannabis. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Supreme Cannabis. Aurora Cannabis' average media sentiment score of 1.85 beat Supreme Cannabis' score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Overall Sentiment
Aurora Cannabis Very Positive
Supreme Cannabis Neutral

Aurora Cannabis currently has a consensus target price of C$7.17, suggesting a potential upside of 90.10%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts plainly believe Aurora Cannabis is more favorable than Supreme Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Supreme Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Aurora Cannabis beats Supreme Cannabis on 8 of the 13 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$234.14MC$2.25BC$6.88BC$12.48B
Dividend YieldN/A2.81%2.67%6.19%
P/E Ratio-1.765.0427.0836.95
Price / Sales0.731,642.24495.869.44
Price / Cash1.2510.1850.5482.29
Price / Book0.429.9110.284.39
Net Income-C$44.16MC$20.27BC$3.60BC$299.09M
7 Day Performance1.89%-0.89%-1.27%0.61%
1 Month Performance-4.07%0.06%-0.36%1.06%
1 Year Performance-43.14%7.14%18.31%30.89%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
2.4765 of 5 stars
C$3.77
-0.3%
C$7.17
+90.1%
-42.4%C$234.14MC$320.59MN/A1,073
TLRY
Tilray Brands
1.3165 of 5 stars
C$6.00
+0.7%
C$13.30
+121.7%
-43.4%C$740.74MC$858.28MN/A2,650
WEED
Canopy Growth
2.0802 of 5 stars
C$1.32
+0.8%
C$1.88
+42.0%
-16.4%C$557.25MC$284.60MN/A2,700
CPH
Cipher Pharmaceuticals
0.4834 of 5 stars
C$16.57
+0.9%
C$17.00
+2.6%
+29.6%C$420.73MC$50.94M13.925
SUGR
SugarBud Craft Growers
N/AC$11.37
+0.9%
N/A-14.3%C$273.67MC$662.89M8.1244

Related Companies and Tools


This page (TSE:ACB) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners